NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 3 filers reported holding NATERA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,549 | -9.0% | 396,502 | 0.0% | 0.12% | -9.4% |
| Q2 2023 | $19,294 | -12.4% | 396,502 | -0.1% | 0.13% | -17.5% |
| Q1 2023 | $22,026 | +115.0% | 396,728 | +55.6% | 0.15% | +100.0% |
| Q4 2022 | $10,243 | -98.1% | 254,989 | +1587.1% | 0.08% | +1825.0% |
| Q2 2022 | $536,000 | +23.8% | 15,114 | +42.0% | 0.00% | +33.3% |
| Q1 2022 | $433,000 | -70.8% | 10,644 | -33.2% | 0.00% | -62.5% |
| Q4 2021 | $1,484,000 | -16.4% | 15,928 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $1,775,000 | -6.7% | 15,928 | -5.0% | 0.01% | -16.7% |
| Q2 2021 | $1,903,000 | +15.1% | 16,765 | +3.0% | 0.01% | +9.1% |
| Q1 2021 | $1,653,000 | +1.1% | 16,282 | -0.9% | 0.01% | 0.0% |
| Q4 2020 | $1,635,000 | +2.6% | 16,431 | -25.5% | 0.01% | -8.3% |
| Q3 2020 | $1,594,000 | +540.2% | 22,066 | +341.5% | 0.01% | +500.0% |
| Q2 2020 | $249,000 | +85.8% | 4,998 | +11.1% | 0.00% | +100.0% |
| Q1 2020 | $134,000 | -11.8% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $152,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 3,100,560 | $352,007,000 | 20.29% |
| Blue Water Life Science Advisors, LP | 457,981 | $51,994,000 | 19.56% |
| Foresite Capital Management III, LLC | 127,305 | $14,453,000 | 15.32% |
| Eagle Health Investments LP | 163,194 | $18,527,000 | 6.36% |
| Ally Bridge Group (NY) LLC | 218,000 | $24,750,000 | 6.15% |
| Lagoda Investment Management, L.P. | 101,590 | $11,534,000 | 5.37% |
| HWG Holdings LP | 95,565 | $10,883,000 | 4.71% |
| Hudson Executive Capital LP | 588,886 | $66,856,000 | 4.44% |
| BRIDGER MANAGEMENT, LLC | 393,620 | $44,688,000 | 4.17% |
| PERKINS CAPITAL MANAGEMENT INC | 62,450 | $7,090,000 | 4.02% |